Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the "Company” or "Eagle”) today announced that its Board of Directors (the ...

Investors who purchased or acquired Fluence securities during the Class Period may, no later than MAY 12, 2025, seek to be appointed as a lead plaintiff representative of the class. To learn your ...

Investor Deadline: Investors who purchased or acquired AppLovin securities during the Class Period may, no later than MAY 5, 2025, seek to be appointed as a lead plaintiff representative of the class.

Click here for more https://monteverdelaw.com/case/northstar-healthcare-income-inc-nhhs/. It is free and there is no cost or obligation to you. Keen Vision ...

It’s the first time since the 2018 cycle that casinos and other gaming groups donated more than any other industry, and the ...

Delaware legislators introduced proposed Senate Bill 21, providing for amendments to Sections 144 and 220 of the ...

The Hoffmann Family of Companies, which invests in and in some cases manages a wide portfolio of assets, says it will seek a ...

Subsequently, Strine joined the most profitable corporate law firm in the country, bought a home in Martha’s Vineyard, and ...

The decision comes as Department of Government Efficiency (DOGE) head Elon Musk said he believes the US Postal Service and ...

On February 17, 2025, the Delaware General Assembly introduced a bill seeking to amend two sections in the General ...

Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the "Company" or "Eagle") today announced that its Board of Directors (the "Board") has approved ...